Planning Capital Management Corp »

Oncolytics Biotech shares owned by Planning Capital Management Corp

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Planning Capital Management Corp from 13F filings

Historical chart of Planning Capital Management Corp investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Planning Capital Management Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Planning Capital Management Corp

Quarter filed Position value Share count Share price at filing
2023-12-31 $291 215 1.35

More positions owned by Planning Capital Management Corp

Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Merck & Co (MRK)
Lockheed Martin Corporation (LMT)
Johnson & Johnson (JNJ)
Wal-Mart Stores (WMT)
Verizon Communications (VZ)
Southern Company (SO)
Coca-Cola Company (KO)
McDonald's Corporation (MCD)
Kimberly-Clark Corporation (KMB)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)
Procter & Gamble Company (PG)
DTE Energy Company (DTE)
Kellogg Company (K)

View all positions for Planning Capital Management Corp

Top funds holding Oncolytics Biotech

International Assets Investment Management
Millennium Management
Citadel Advisors
Commonwealth Equity Services
Royal Bank of Canada
Long Focus Capital Management
Bank Of Montreal
Ausdal Financial Partners
Brave Asset Management
Two Sigma Securities
C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors
Banque Cantonale Vaudoise
Headinvest
Jpmorgan Chase & Co
Kingsview Wealth Management

View all funds holding Oncolytics Biotech